Latest news
Kelun-Biotech's Sac-TMT Gains NMPA Review for First-Line Advanced TNBC Indication - BioPharm InternationalBioPharm International · Thu, 30 Jul 2026 17:19:38 GMTNMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC - The Manila TimesThe Manila Times · Thu, 30 Jul 2026 07:00:00 GMT